Plain-English translation of NCT07713615 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying people who have implanted heart devices (like pacemakers) that have detected episodes of irregular heartbeats. Some patients with these device-detected rhythm changes have a higher stroke risk, but doctors currently struggle to figure out who needs blood-thinning medication and who doesn't. This study will examine blood clotting markers and heart ultrasound images to better predict which patients are most at risk.
Doctors need better ways to identify which patients with these subtle, device-detected heart rhythm problems should take blood-thinning medications to prevent stroke. Current methods don't fully account for clotting markers or changes in heart structure that may increase risk.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for a baseline assessment where you'll have blood drawn, a heart ultrasound performed, and your device checked to measure how often you're having irregular heartbeats. You'll then be followed for up to 10 years with periodic check-ins to track your health and any heart-related events. The study compares your results to people with similar heart devices who haven't had detected rhythm problems.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Denmark